Human papillomavirus and the population research on cervical cancer: test implementation of the hrHPV tests in the population research cervical cancer New Style.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 44,102
研究概览
简要总结
NWJ Bulkmans, L Rozendaal, PJF Snijders, FJ Voorhorst, AJP Boeke, GRJ Zandwijken, FJ van Kemenade, RHM Verheijen, K v Groningen, ME Boon, HJF Keuning, M van Ballegooijen, AJC van den Brule, CJLM Meijer. POBASCAM, a population-based randomised controlled trial for implementation of high-risk HPV testing in cervical screening; Design, methods and baseline data of 44,102 women. International Journal of Cancer 2004; 110 (1): 94-101. DOI 10.1002/ijc.20076
- NWJ Bulkmans, MCG Bleeker, J Berkhof, FJ Voorhorst, PJF Snijders, CJLM Meijer. Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse. International Journal of Cancer 2005; 117 (2): 177-181. DOI: 10.1002/ijc.21210
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Women invited for the cervical cancer screening program (ages 30-60 years);
- •2. Residing in either the region covered by district health authority Amstelland-de Meerlanden and Zuid-Kennemerland.
排除标准
- •1. Not called for screening, i.e., ages under 30 years, or over 60 years;
- •2. Follow-up of previous non-normal cytology within the current screening round of the program, i.e., abnormal cytology or CIN lesions less than 2 years before inclusion;